Myoclonic-Atonic Epilepsy (MAE), Doose Syndrome

Sponsored diagnostic testing programs for Myoclonic-Atonic Epilepsy (MAE), Doose Syndrome

Myoclonic-atonic epilepsy (Doose syndrome) is an early childhood-onset generalized epilepsy characterized by myoclonic, atonic, and absence seizures, with risk of drop attacks and falls. Development is often normal before seizure onset, but some children experience cognitive or behavioral difficulties over time. Genetic testing can identify monogenic causes and inform treatment choices and prognosis.

1 program found for Myoclonic-Atonic Epilepsy (MAE), Doose Syndrome

Programs

1 program
Invitae Unlock™

Invitae Epilepsy Panel

This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.

Neurology
ViewOrder
Performing labInvitae | Labcorp